Proteomics to Identify Disease-Associated Variants in Patients with Rare Disease Undiagnosed After Genome Sequencing

Wednesday, January 27, 2027 at 11:30 AM to 12:00 PM · 30 min. (Europe/London)
Multi-Omics Stage
Day 1 - Wednesday 27th January
Proteomics

Information

In this session you can expect to cover:

  • Discussion our proof-of-principle study to explore the potential of circulating proteomics to improve the diagnostic yield in patients with rare diseases from the 100,000 Genomes project (100kGP) 
  • Detection of lower serum protein ‘outliers’ can help resolve VUS or prioritise genes for targeted reanalysis of GS data to provide genetic diagnoses to undiagnosed patients after WGS. 
  • Broad-capture blood proteomic technologies can support identification of new candidate rare disease genes.